Background: Insulin and age affect leucine (and protein) kinetics in vivo. However, to our knowledge, leucine transamination and the effects of insulin have not been studied in participants of different ages.
Introduction
Insulin controls a variety of metabolic steps in leucine and protein turnover in humans (1, 2) . At the whole-body level, its main effect is the suppression of leucine release from endogenous protein breakdown (3) (4) (5) . Conversely, insulin infusion in vivo apparently does not stimulate whole-body leucine disposal to protein synthesis if plasma amino acids are allowed to decrease (6, 7) , whereas a stimulatory effect is shown if plasma amino acids are maintained at basal levels (8) . In contrast, the insulin effect on irreversible leucine loss to oxidation is controversial because no changes (P Tessari, S Inchiostro, G Biolo, E Vincenti, L Sabadin, unpublished results, 1991), a reduction (6) , or a stimulation (9) have been reported even when isoaminoacidemia is maintained. However, to our knowledge, the insulin effect on another important leucine metabolic step, transamination, has been poorly studied.
Transamination is the first reaction of amino acid catabolism (10) . The term ''transamination'' indicates the transfer of an amino group from a donor amino acid to an accepting keto acid to form another amino acid. Because transamination is a reversible reaction, it is composed of 2 opposite steps, i.e., deamination (the transfer of the amino group to a keto acid) and reamination (the capture of an amino group by a keto acid to form an amino acid). All these steps are important checkpoints of amino acid metabolism and catabolism (10, 11) .
BCAA transamination plays a key role in nitrogen distribution among nonessential amino acids as well as in its disposal to urea formation (11) . Therefore, the regulation by insulin at this early step may be important also in the further metabolic partitioning of the amino acid carbon skeleton to either oxidation or protein synthesis.
Aging is characterized by a progressive loss of lean body mass (LBM) and muscle strength and function, leading to the wasting condition known as ''sarcopenia'' (12) . The causes of sarcopenia are only partially known. Many investigations have been carried out to detect the possible metabolic defects associated with such a condition.
Early in vivo studies failed to show an impairment of either insulin-mediated suppression of whole-body proteolysis or of protein synthesis in aged individuals (13, 14) . This is in contrast with a decreased insulin sensitivity to glucose disposal commonly observed with aging (15) . However, in subsequent studies, a reduced anabolic effect of insulin in the stimulation of protein synthesis in aging was demonstrated, which is associated with a reduced fat-free mass and an increased adiposity (16) . A resistance or delay to the anabolic utilization of amino acids has been reported in aging, too (17) (18) (19) . Furthermore, decreased skeletal muscle protein and ATP synthesis have been observed in aged individuals, with appreciable effects being detected even in middle-aged individuals compared with younger controls (20) .
Leucine is widely used as a marker of body protein turnover (1-9). However, the effects of aging, also in combination with hyperinsulinemia, on the first leucine metabolic step, i.e., transamination, have never been investigated to my knowledge.
Therefore, the aim of this study was to determine the rates of leucine deamination and reamination and the effects of hyperinsulinemia, in middle-aged subjects, i.e., at an age when body and muscle protein turnover appear to be already altered. A refined model to measure transamination was developed and applied to the raw data generated in previous studies (5, 21) but never published as such before.
Methods
Subjects. Healthy volunteers were enrolled and studied between September 1993 and July 1994. [As anticipated above, the raw data, i.e., plasma leucine-and a-ketoisocaproate (KIC)-specific activities and concentrations, as well as the radiolabeled expired 14 CO 2 , were measured at the time of the referenced studies (5, 21) ; however, the model to measure leucine transamination has been developed only recently and never published before.] The protocols had been approved by the Institutional Review Board of the University of Padova, Italy. The subjects had no personal or family history of diabetes, and their fasting plasma glucose and glycated hemoglobin values were within the normal range (between 3.9 and 5.6 mmol/L, i.e., between 4% and 5.5%). Their clinical and biochemical characteristics are reported in Table 1 . The subjects were arbitrarily divided into a younger (<33 y old) and a middle-aged (>40 y old) group. The younger group consisted of 9 subjects (8 men, 1 woman), and the middle-aged group consisted of 9 subjects (7 men, 2 women) with BMI (in kg/m 2 ) and LBM (the latter estimated by HumeÕs formula) (22) similar to those of the younger group (Table 1) .
Isotopes. The L-4,5-[ 3 H]leucine [ 3 H-Leu; specific activity (SA): 55 Ci/mol] and the L-[1-14 C]leucine ( 14 C-Leu, SA: 57 Ci/mol) were purchased from Amersham Int. The 14 C-KIC was prepared from the 14 C-Leu as described elsewhere (23) . Briefly, after the enzymatic conversion of the 14 C-Leu tracer to 14 C-KIC, following the method of Rü diger et al. (24) , the 14 C-KIC product was isolated and selectively collected by HPLC. The purity of the resulting 14 C-KIC tracer was excellent (>95%). The tracer was filtered through a 0.2-mm Millipore filter and tested for purity, sterility, and apyrogenicity before use.
Study description. The isotope infusion studies and the euglycemic, hyperinsulinemic clamp were performed as previously reported (5, 21) . Briefly, after a preinfusion blood sample, priming doses (;30 times the continuous infusion rate per minute) of the 3 H-Leu and 14 C-KIC tracers, as well as a priming dose of 14 C-bicarbonate (5 mCi), were administered at ;0800 (time: 2150 min). Thereafter, the 3 H-Leu and 14 C-KIC tracers were infused at a constant rate for 150 min until time = 0 min in the subjects studied only in the postabsorptive state. In the last 30 min, i.e., at the steady state of substrate concentrations and tracer specific activities (data not shown), 4 arterialized venous blood and expired air samples were collected at 10-min intervals for basal measurements of the substrate and hormone concentrations, of the 3 H-and 14 C-KIC leucine and KIC SAs, and of expired 14 CO 2 .
In 5 younger (5 men) and 6 middle-aged (4 men, 2 women) subjects, a euglycemic, hyperinsulinemic clamp was started at t = 0 min and carried out for an additional ;150 min. Insulin was diluted in saline solution with the addition of 2 mL of each subjectsÕ own blood and infused at the rate of 0.05 U Á m 22 (body surface) Á min 21 . The plasma glucose concentration was frequently monitored by a Beckman Glucose Analyzer 2 (Beckman Instruments), and euglycemia (target values: 4.7-5 mmol/L) was maintained by a variable 20% glucose infusion. In the last 30 min, 4 arterialized venous blood and breath samples were again collected at 10min intervals for measurements at the new steady state (7) .
Blood and breath analyses. Leucine and KIC concentrations and SAs were determined according to Nissen et al. (25) and that of the expired 14 CO 2 as reported in detail previously (7) . Whole-body glucose disposal was classically calculated from the rate of the glucose infusion to maintain euglycemia at steady state in the last 30 min of the clamp period. At the insulin concentrations attained during the clamp, endogenous glucose production is completely suppressed; therefore, the exogenous glucose infusion is equal to whole-body disposal (26) .
Model of leucine deamination and reamination. Because 2 independent tracers, one of leucine ( 3 H-Leu) and another of KIC ( 14 C-KIC), were infused, their interconversion rates, therefore also the rates of leucine deamination and KIC reamination, could be estimated ( Figure 1) . Two slightly different models were developed (as detailed in the Supplemental Material). The basic assumption of both models is that each infused isotope (i.e., either the 3 H-Leu or the 14 C-KIC) is used to trace the appearance into the plasma space of the companion, differently labeled compound, i.e., either the 14 C-Leu or the 3 H-KIC, respectively, each of them resulting from leucine and KIC in vivo interconversion. A similar approach has been previously applied to calculate the appearance of an orally administered leucine by using a differently labeled leucine tracer infused intravenously (27) . Another assumption is that the plasma 3 H-KIC SA, resulting from the infusion of 3 H-Leu, is equivalent to the intracellular 3 H-Leu SA (28), according to the ''reciprocal pool'' model concept (29) . A third assumption, or constraint, of both models is the use of the plasma 14 Statistical analysis. All data were reported as means 6 SEs. The leucine kinetic data were expressed relative either to body weight or to LBM (both expressed in kg). The statistical analysis was performed by using the 2-tailed StudentÕs t test for either unpaired data or means in the comparison of a single set of data between the 2 groups (i.e., the basal data between the younger and the middle-aged group). The 2-tailed StudentÕs t test for paired data was used for the comparisons of 2 sets of data within each group. The 2-factor ANOVA for repeated measurements was used in the comparisons of the basal and clamp data between the 2 groups. Simple correlation analysis (using the Pearson correlation coefficient) was performed between 2 sets of data as indicated. The Statistica Software (Version 4; StatSoft Inc.) was used for all analyses. A P value #0.05 was considered statistically significant.
Results
The isotope infusion rates, the rate of 14 CO 2 expiration, and the leucine and KIC [ 3 H] and [ 14 C] plasma SAs are reported in Table  2 . Data are indicated separately for the 2 sets of comparisons and experiments, i.e., for all the subjects who underwent the basal, postabsorptive study and for those (i.e., subgroups of the former) who were studied in both the basal and the clamp periods.
Postabsorptive state. The leucine and KIC concentrations were similar in the younger and the middle-aged subjects ( Table  2 ). In all subjects, leucine deamination was significantly greater than reamination ( Table 3) .
When expressed relative to body weight, in the middle-aged group postabsorptive leucine deamination, reamination, and net deamination rates were significantly lower (P < 0.002, P < 0.05, and P < 0.015 respectively) than the corresponding rates of the younger group by~30%. When expressed relative to LBM, the results were not substantially different, with the exception of a borderline significant between-group difference in reamination (P = 0.064) ( Table 3 ). No differences between the middle-aged and the younger subjects were observed regarding the leucine Ra and leucine disposal into protein synthesis (Table 3) .
Clamp studies. Plasma insulin was increased from 53 6 8 to 643 6 68 pmol/L in the younger adults and from 60 6 7 to 875 6 130 pmol/L in the middle-aged group. The insulin concentrations attained in the clamp period were similar in the 2 groups (P = 0.18 between groups). Plasma glucose was kept at the same concentration (;90 mg/dL, i.e., at 5 mmol/L) in both groups. The leucine and KIC concentrations decreased to the same extent in both the middle-aged and the younger subjects ( Table 2 ). In the former group, insulin-mediated glucose disposal to maintain euglycemia was 30-40% lower than that in the younger group when expressed relative to either body weight [7.14 6 0.70 mg/(kg 3 min) compared with 11.4 6 0.80 mg/(kg 3 min)] (P < 0.007) or LBM [9.3 6 0.7 mg/(kg LBM 3 min) compared with 13.3 6 1.2 mg/(kg LBM 3 min)] (P < 0.015).
After the clamp, both leucine deamination and KIC reamination were significantly suppressed in both groups ( Figure  2) . However, in the middle-aged subjects both rates remained significant lower than those of the younger group.
Leucine Ra (proteolysis) was suppressed by ;15% in both the younger group, from 2.35 6 0.12 to 2.15 6 0.19 mmol/(kg 3 min) (P < 0.015 compared with basal by the 2-tailed StudentÕs t test for paired data) and the middle-aged group, from 2.43 6 0.19 to 1.96 6 0.16 mmol/(kg 3 min) (P < 0.012 compared with basal) to similar levels in the 2 groups. Leucine disposal to protein synthesis was also decreased with hyperinsulinemia (P < 0.035) by ;12% in the younger group, from 2.15 6 0.15 to 1.90 6 0.20 mmol/(kg 3 min) and by ;18% in the middle-aged group, from 2.17 6 0.16 to 1.79 6 0.13 mmol/(kg 3 min), without differences between the groups.
Correlations. When only the basal data were considered, reamination was directly correlated to KIC concentrations (r = 0.526, P < 0.025), whereas the correlation between deamination and leucine concentration only approached statistical significance (r = 0.16, P < 0.06). When the basal and the clamp data were considered together, deamination was directly correlated to leucine concentrations (r = 0.61, P < 0.0025) as was reamination to KIC concentrations (r = 0.79, P < 0.00002).
Discussion
I report here data on leucine transamination rates (i.e., deamination and reamination), with respect to age as well as to the insulin effect, using a model based on the simultaneous infusion of leucine and KIC tracers.
First, leucine deamination was consistently greater than reamination in all subjects, both in the postabsorptive and in the hyperinsulinemic state. Second, the deamination and reamination rates were ;20-30% lower in the middle-aged group than in the younger group. Third, insulin decreased leucine transamination rates to the same extent in both younger and middle-aged individuals. These data indicate that leucine transamination is affected by age as well as by insulin. Unfortunately, no data on older subjects were available. However, it has been previously reported that specific alterations in protein turnover, such as the fractional protein synthesis of myosin heavy chain and mitochondrial activity, are already lower in middle-aged than in younger subjects, with further decrements observed in older subjects (20) . Thus, my as well as these previously published data support the view that middle age in otherwise healthy subjects is associated with measurable alterations of leucine and protein turnover. Leucine deamination is catalyzed by vitamin B-6-dependent branched-chain aminotransferase isoenzymes (BCATs) that regulate the production of branched-chain a-keto acids (10, 11) . The subsequent metabolic step of the branched-chain a-keto acids is their irreversible loss through oxidative decarboxylation, mediated by the branched-chain a-keto acid dehydrogenase enzyme complex. In has been previously reported that the BCAT and the branched-chain a-keto acid dehydrogenase enzymes are closely associated and build up a supramolecular entity, known as ''metabolon,'' that functions as a coordinated complex to regulate leucine catabolism (30) . Although plasma vitamin B-6 concentration was not measured, it would be more indicative of BCAT activity if determined within the mitochondria. In addition, I did not strictly measure leucine oxidation but rather KIC oxidation; therefore, I cannot provide a comprehensive picture of the in vivo operation of the ''metabolon'' under the present experimental conditions. Further studies might be required to test this model in vivo also in response to aging and hyperinsulinemia.
Euglycemic hyperinsulinemia reduced leucine transamination by the same extent in both groups. Consequently, lower rates in middle-aged adults than in the younger group were maintained. Thus, no age-related resistance to the inhibitory effect of insulin on leucine transamination was observed, similar to what was observed on the insulin-mediated inhibition of proteolysis (present data and those of references 13, 14) . The reduction of leucine concentration to similar absolute levels in both groups may explain the also similar reduction of transamination, which is a substrate-dependent reaction (31) . In this respect, the direct correlations between deamination and leucine concentrations, as well as between reamination and KIC concentrations, further support the view that reversible leucine and KIC deamination and reamination are substrate dependent.
A role for a decreased leucine (and KIC) transport across the cell membrane with aging cannot be excluded, too. Data about age effects on amino acid transport are scarce. In an in vitro animal cell model (opossum kidney proximal tubular cells), subjected to repeated passages to simulate an aging process, leucine transport was actually increased, whereas that of alanine was decreased (32) . In contrast, in rat brain an age-dependent reduction of BCAA transport has been reported (33) . Therefore, a decreased amino acid transport in aging tissues, organs, living animals, or humans can be neither proven nor excluded. Whatever the reason, a decreased leucine transamination might be functional in reducing leucine catabolism. In this respect, the estimate of protein synthesis did not differ significantly between younger adults and middle-aged subjects (Table 3) . Indeed, protein synthesis was inhibited and to the same extent by hyperinsulinemia in both groups, likely because the leucine concentration, as well as that of most other amino acids, was reduced (21), thus limiting an insulin effect on protein synthesis.
Other models had previously been used to measure leucine and KIC transamination and interconversion in vivo (34, 35) . The model from Matthews et al. (34) was based on the infusion of a doubly labeled [ 13 C, 15 N] stable isotope of leucine as a single tracer. The 2-pool model from Nissen and Haymond (35) used the simultaneous infusions of 2 independent leucine and KIC tracers and a series of simultaneous equations to solve the exchange rates between the 2 pools (one of leucine and one of KIC). Although in the present study 2 independent leucine and KIC tracers were also used, the exchange rates between the leucine and the KIC pools were calculated with the general Fick principle applied to isotope dilution methods, rather than using simultaneous equations. In addition, a (partial) distinction between the extracellular and intracellular pools leucine and KIC pools was introduced here. It is, however, reassuring that the direction of changes of the insulin-induced effects of leucine transamination (i.e., on leucine-KIC interconversion) is similar in the present as well as in previous studies (5, 21) .
The only real constraint applied to this model is the use of the plasma 14 C-KIC SA as the surrogate of the intracellular one. Although the intracellular 14 C-KIC SA might be somewhat lower than that in plasma, such a difference should be minor because the intracellular KIC pool is small (31, 36) (most of plasma KIC is bound to protein, predominantly albumin) (37), whereas its turnover is relatively fast (23) . Therefore, its fractional turnover should be high, thus favoring a rapid equilibration between extracellular and intracellular pool(s). Furthermore, the possible underestimation of net deamination would be minor because of the simultaneous underestimation of both the deamination and reamination reactions as detailed in the Supplemental Model Equations 3, 4, and 6.
In contrast to the finding of a similar response to insulin in the 2 age groups of both proteolysis and protein synthesis, the middle-aged subjects were insulin resistant regarding glucose disposal, which was ;30-40% lower than that of the younger group, whether expressed relative to LBM or body weight. Thus, these data confirm that, in middle age, insulin resistance to glucose is extended neither to leucine (amino acid) kinetics (13, 14) nor, as a novel finding, to the branched-chain aminotransferase activity.
In conclusion, this study shows that leucine transamination rates are reduced in middle age, both in the postabsorptive state and after hyperinsulinemia. The relative response to insulin is, however, normal, showing no insulin resistance of leucine kinetics also at the transamination step.
